Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
- Conditions
- Candidiasis, EsophagealHIV Infections
- Registration Number
- NCT00002132
- Lead Sponsor
- Janssen Pharmaceuticals
- Brief Summary
To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (18)
Dr Eskild A Petersen
🇺🇸Tucson, Arizona, United States
Los Angeles County - USC Med Ctr
🇺🇸Los Angeles, California, United States
UCSD Med Ctr
🇺🇸San Diego, California, United States
George Washington Univ Med Ctr
🇺🇸Washington, District of Columbia, United States
Emory Univ School of Medicine
🇺🇸Atlanta, Georgia, United States
Rush Presbyterian - Saint Luke's Med Ctr
🇺🇸Chicago, Illinois, United States
Johns Hopkins Univ School of Medicine
🇺🇸Baltimore, Maryland, United States
Wayne State Univ / Harper Hosp
🇺🇸Detroit, Michigan, United States
Univ of Missouri at Kansas City School of Medicine
🇺🇸Kansas City, Missouri, United States
Infectious Diseases Association / Research Med Ctr
🇺🇸Kansas City, Missouri, United States
Scroll for more (8 remaining)Dr Eskild A Petersen🇺🇸Tucson, Arizona, United States